SMLR - Semler Scientific plunges after first quarterly contraction in over a year

Semler Scientific (SMLR -27.4%) has shed over a fifth on Tuesday to record the biggest intraday loss in nearly four months after the healthcare equipment maker reported worse than expected results for Q4 2021. Marking the first revenue contraction in five quarters, the Q4 2021 revenue fell ~4% YoY to reach $11.5M. However, full-year revenue climbed ~37% YoY to $53.0M from ~8% YoY decline recorded in 2020. Net income for the quarter and full-year surged ~72% YoY and ~23% YoY to $1.5M and $17.2M, respectively, while cash at the end of the year stood at $37.3M compared to $22.1M a year ago. In Q4 2021, the fixed-fee license revenues rose ~13% YoY to ~$7.9M, while variable-fee license revenues dropped ~13% YoY to $3.5M. Ahead of the earnings call, chief executive Doug Murphy-Chutorian explained the reasons for the underperformance. "In 2021 as compared to 2020, we experienced a timing shift in the home-testing

For further details see:

Semler Scientific plunges after first quarterly contraction in over a year